On November 16th, the ITT Corporation (White Plains, New York) acquired O.I. Corporation for a reported $29 million. The acquisition will enhance ITT?s analytical instrumentation business, which was started earlier this year.
On November 16th, the ITT Corporation (White Plains, New York) acquired O.I. Corporation for a reported $29 million. The acquisition will enhance ITT’s analytical instrumentation business, which was started earlier this year.
According to the company’s press release, OI is, the leading provider of innovative instrumentation for laboratory and environmental testing in the pharmaceutical, petrochemical, power and industrial markets.
Founded in 1963, OI specializes in innovative total organic carbon (TOC) analyzers and gas chromatography-related instrumentation.
“The addition of OI to our existing portfolio supports our strategy to acquire attractive companies to grow our presence in the $6 billion global analytical instrumentation market,” said Chris McIntire, president of ITT Analytics.
“Combining OI with our own product offering allows us to expand our technical expertise to serve our instrumentation customers, and will enable us to better serve our global customers,” McIntire added.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.